Number of items: 6.
Article
Williams, T, Wadeley, A, Bond, D, Cavill, C, Freeth, M and Sengupta, R
(2020)
'Real-world experience of secukinumab treatment for ankylosing spondylitis at the Royal National Hospital for Rheumatic Diseases, Bath.'
Clinical Rheumatology, 39.
pp. 1501-1504.
Williams, T, Gaffney, K, Wadeley, A, Cavill, C, Freeth, M, Brooksby, A and Sengupta, R
(2019)
'THU0408 Achieving disease remission in axial spondyloarthritis: a two-centre retrospectice analysis of relevant baselines patient characteristics.'
Annals of the Rheumatic Diseases, 78 (Sup. 2).
p. 490.
Other
Williams, T, Wadeley, A, Cavill, C, Freeth, M and Sengupta, R
(2019)
269 - In axial spondyloarthritis, magnitude of improved disease activity after six months of biologic disease-modifying treatment may be more relevant to short-term functional outcome than achieving an inactive disease state [conference abstract].
Rheumatology, 58 (Sup. 3).
Please click the title to check availability.
This list was generated from
ResearchSPAce on
Sun Apr 27 19:19:09 2025 UTC.